Skip to content
Boost Up Blog – Lifestyle
Author:
BriaCell Therapeutics Corp.
Data Safety Monitoring Board (DSMB) Recommends Continuing BriaCell’s Phase 3 Metastatic Breast Cancer Study
September 14, 2026
BriaCell Phase 3 Metastatic Breast Cancer Trial Expands to MSK
September 8, 2026
BriaCell Receives FDA Clearance to Initiate Bria-PROS+™ Clinical Study in Prostate Cancer
August 5, 2026
BriaCell Opens First Canadian Site – Sunnybrook – for Pivotal Phase 3 Trial in Metastatic Breast Cancer
July 16, 2026
BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT™
July 15, 2026
BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT™
July 7, 2026
BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT™
June 25, 2026
BriaCell Therapeutics Announces Closing of Offering
June 2, 2026
BriaCell Presents Positive Clinical Data at ASCO 2026
June 1, 2026
BriaCell Therapeutics Announces Pricing of Offering
May 31, 2026
1
2
3
Next Page
→